These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 16172233)

  • 1. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
    Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
    Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
    Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
    Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
    Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
    Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
    Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families.
    Goldstein AM; Martinez M; Tucker MA; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):889-94. PubMed ID: 11008905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
    de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
    Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
    Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
    Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDKN2A mutations in melanoma families from Uruguay.
    Larre Borges A; Cuéllar F; Puig-Butillé JA; Scarone M; Delgado L; Badenas C; Milà M; Malvehy J; Barquet V; Núñez J; Laporte M; Fernández G; Levrero P; Martínez-Asuaga M; Puig S
    Br J Dermatol; 2009 Sep; 161(3):536-41. PubMed ID: 19523171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Swedish CDKN2A mutation carriers do not present the atypical mole syndrome phenotype.
    Nielsen K; Harbst K; Måsbäck A; Jönsson G; Borg A; Olsson H; Ingvar C
    Melanoma Res; 2010 Aug; 20(4):266-72. PubMed ID: 20526219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
    Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma.
    Kanetsky PA; Rebbeck TR; Hummer AJ; Panossian S; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Culver HA; Zanetti R; Gallagher RP; Dwyer T; Busam K; From L; Mujumdar U; Wilcox H; Begg CB; Berwick M
    Cancer Res; 2006 Sep; 66(18):9330-7. PubMed ID: 16982779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
    Goldstein AM; Chaudru V; Ghiorzo P; Badenas C; Malvehy J; Pastorino L; Laud K; Hulley B; Avril MF; Puig-Butille JA; Miniere A; Marti R; Chompret A; Cuellar F; Kolm I; Mila M; Tucker MA; Demenais F; Bianchi-Scarra G; Puig S; de-Paillerets BB
    Int J Cancer; 2007 Aug; 121(4):825-31. PubMed ID: 17397031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
    Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
    Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple primary melanoma revisited.
    Blackwood MA; Holmes R; Synnestvedt M; Young M; George C; Yang H; Elder DE; Schuchter LM; Guerry D; Ganguly A
    Cancer; 2002 Apr; 94(8):2248-55. PubMed ID: 12001124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MC1R, ASIP, TYR, and TYRP1 gene variants in a population-based series of multiple primary melanomas.
    Helsing P; Nymoen DA; Rootwelt H; Vårdal M; Akslen LA; Molven A; Andresen PA
    Genes Chromosomes Cancer; 2012 Jul; 51(7):654-61. PubMed ID: 22447455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment.
    Kannengiesser C; Dalle S; Leccia MT; Avril MF; Bonadona V; Chompret A; Lasset C; Leroux D; Thomas L; Lesueur F; Lenoir G; Sarasin A; Bressac-de Paillerets B
    Genes Chromosomes Cancer; 2007 Aug; 46(8):751-60. PubMed ID: 17492760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of melanocortin 1 receptor gene polymorphisms and the agouti signalling protein gene 8818A>G polymorphism to cutaneous melanoma and basal cell carcinoma in a Polish population.
    Brudnik U; Branicki W; Wojas-Pelc A; Kanas P
    Exp Dermatol; 2009 Feb; 18(2):167-74. PubMed ID: 18637131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.